In a regulatory filing, Ligand disclosed that its CEO Todd Davis bought 4K shares of common stock on September 22nd in a total transaction size of $237.5K.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LGND:
- Ligand’s partner Jazz Pharmaceuticals receives EC approval for Enrylaze
- Ligand raises FY23 EPS to $5.10-$5.25 from $4.85-$5.00, consensus $4.98
- Ligand spins out and merges Pelican subsidiary with Primordial Genetics
- Ligand raises FY23 EPS from $4.60-$4.75 to $4.85-$5.00, consensus $4.63
- Ligand reports Q2 EPS $1.42, consensus 64c